CJC-1295 (with DAC)

CJC-1295 with DAC is a research peptide designed as a modified version of growth hormone-releasing hormone (GHRH). By incorporating a Drug Affinity Complex (DAC), CJC-1295 demonstrates a significantly extended half-life compared to non-DAC analogues, allowing for more sustained activity in experimental settings.

In scientific research, CJC-1295 (w/ DAC) is used to:

• Stimulate growth hormone release through GHRH receptor activation

• Support metabolic regulation in scientific studies

• Provide a prolonged peptide profile compared to standard CJC-1295 (No-DAC)

• Purity: >99% 
• Form: Lyophilised powder
• Storage: Store dry at -20°C; protect from light
• Solubility: Bacteriostatic water, sterile water, or suitable laboratory solvents
• Storage reconstituted: Store refrigerated (2-8°C)